These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 27021278)

  • 1. From statistical significance to clinical relevance: A simple algorithm to integrate brain natriuretic peptide and the Seattle Heart Failure Model for risk stratification in heart failure.
    AbouEzzeddine OF; French B; Mirzoyev SA; Jaffe AS; Levy WC; Fang JC; Sweitzer NK; Cappola TP; Redfield MM
    J Heart Lung Transplant; 2016 Jun; 35(6):714-21. PubMed ID: 27021278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the Seattle Heart Failure Model in a community-based heart failure population and enhancement by adding B-type natriuretic peptide.
    May HT; Horne BD; Levy WC; Kfoury AG; Rasmusson KD; Linker DT; Mozaffarian D; Anderson JL; Renlund DG
    Am J Cardiol; 2007 Aug; 100(4):697-700. PubMed ID: 17697831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prealbumin improves death risk prediction of BNP-added Seattle Heart Failure Model: results from a pilot study in elderly chronic heart failure patients.
    Cabassi A; de Champlain J; Maggiore U; Parenti E; Coghi P; Vicini V; Tedeschi S; Cremaschi E; Binno S; Rocco R; Bonali S; Bianconcini M; Guerra C; Folesani G; Montanari A; Regolisti G; Fiaccadori E
    Int J Cardiol; 2013 Oct; 168(4):3334-9. PubMed ID: 23623341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Four-variable risk model in men and women with heart failure.
    Chyu J; Fonarow GC; Tseng CH; Horwich TB
    Circ Heart Fail; 2014 Jan; 7(1):88-95. PubMed ID: 24281135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How B-Type Natriuretic Peptide (BNP) and Body Weight Changes Vary in Heart Failure With Preserved Ejection Fraction Compared With Reduced Ejection Fraction: Secondary Results of the HABIT (HF Assessment With BNP in the Home) Trial.
    Maisel AS; Shah KS; Barnard D; Jaski B; Frivold G; Marais J; Azer M; Miyamoto MI; Lombardo D; Kelsay D; Iqbal N; Taub PR; Kupfer K; Lee E; Clopton P; Zile M; Greenberg B
    J Card Fail; 2016 Apr; 22(4):283-93. PubMed ID: 26433086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparable prognostic impact of BNP levels among HFpEF, Borderline HFpEF and HFrEF: a report from the CHART-2 Study.
    Kasahara S; Sakata Y; Nochioka K; Yamauchi T; Onose T; Tsuji K; Abe R; Oikawa T; Sato M; Aoyanagi H; Miura M; Shiroto T; Takahashi J; Miyata S; Shimokawa H;
    Heart Vessels; 2018 Sep; 33(9):997-1007. PubMed ID: 29569034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BNP and obesity in acute decompensated heart failure with preserved vs. reduced ejection fraction: The Atherosclerosis Risk in Communities Surveillance Study.
    Khalid U; Wruck LM; Quibrera PM; Bozkurt B; Nambi V; Virani SS; Jneid H; Agarwal S; Chang PP; Loehr L; Basra SS; Rosamond W; Ballantyne CM; Deswal A
    Int J Cardiol; 2017 Apr; 233():61-66. PubMed ID: 28185703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How often we need to measure brain natriuretic peptide (BNP) blood levels in patients admitted to the hospital for acute severe heart failure? Role of serial measurements to improve short-term prognostic stratification.
    Faggiano P; Valle R; Aspromonte N; D'Aloia A; Di Tano G; Barro S; Giovinazzo P; Milani L; Lorusso R; Dei Cas L
    Int J Cardiol; 2010 Apr; 140(1):88-94. PubMed ID: 19321212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation and Recalibration of Seattle Heart Failure Model in Japanese Acute Heart Failure Patients.
    Shiraishi Y; Kohsaka S; Nagai T; Goda A; Mizuno A; Nagatomo Y; Sujino Y; Fukuoka R; Sawano M; Kohno T; Fukuda K; Anzai T; Shadman R; Dardas T; Levy WC; Yoshikawa T
    J Card Fail; 2019 Jul; 25(7):561-567. PubMed ID: 30099192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of the addition of ventilatory efficiency to the Seattle Heart Failure Model in patients with heart failure.
    Levy WC; Arena R; Wagoner LE; Dardas T; Abraham WT
    J Card Fail; 2012 Aug; 18(8):614-9. PubMed ID: 22858076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Which heart failure patients profit from natriuretic peptide guided therapy? A meta-analysis from individual patient data of randomized trials.
    Brunner-La Rocca HP; Eurlings L; Richards AM; Januzzi JL; Pfisterer ME; Dahlström U; Pinto YM; Karlström P; Erntell H; Berger R; Persson H; O'Connor CM; Moertl D; Gaggin HK; Frampton CM; Nicholls MG; Troughton RW
    Eur J Heart Fail; 2015 Dec; 17(12):1252-61. PubMed ID: 26419999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between sex, ejection fraction, and B-type natriuretic peptide levels in patients hospitalized with heart failure and associations with inhospital outcomes: findings from the Get With The Guideline-Heart Failure Registry.
    Hsich EM; Grau-Sepulveda MV; Hernandez AF; Eapen ZJ; Xian Y; Schwamm LH; Bhatt DL; Fonarow GC
    Am Heart J; 2013 Dec; 166(6):1063-1071.e3. PubMed ID: 24268222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adaptive cardiovascular hormones in a spectrum of heart failure phenotypes.
    Zabarovskaja S; Hage C; Linde C; Daubert JC; Donal E; Gabrielsen A; Mellbin L; Lund LH
    Int J Cardiol; 2015; 189():6-11. PubMed ID: 25885866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [BNP-guided therapy optimizes the timing of discharge and the medium term risk stratification in patients admitted for congestive heart failure].
    Valle R; Aspromonte N; Carbonieri E; De Michele G; Di Tano G; Giovinazzo P; Cioè R; Di Giacomo T; Milani L; Noventa F; Chiatto M
    Monaldi Arch Chest Dis; 2007 Sep; 68(3):154-64. PubMed ID: 18361212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiparametric prognostic scores in chronic heart failure with reduced ejection fraction: a long-term comparison.
    Agostoni P; Paolillo S; Mapelli M; Gentile P; Salvioni E; Veglia F; Bonomi A; Corrà U; Lagioia R; Limongelli G; Sinagra G; Cattadori G; Scardovi AB; Metra M; Carubelli V; Scrutinio D; Raimondo R; Emdin M; Piepoli M; Magrì D; Parati G; Caravita S; Re F; Cicoira M; Minà C; Correale M; Frigerio M; Bussotti M; Oliva F; Battaia E; Belardinelli R; Mezzani A; Pastormerlo L; Guazzi M; Badagliacca R; Di Lenarda A; Passino C; Sciomer S; Zambon E; Pacileo G; Ricci R; Apostolo A; Palermo P; Contini M; Clemenza F; Marchese G; Gargiulo P; Binno S; Lombardi C; Passantino A; Filardi PP
    Eur J Heart Fail; 2018 Apr; 20(4):700-710. PubMed ID: 28949086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting 1-Year Mortality in Outpatients With Heart Failure With Reduced Left Ventricular Ejection Fraction: Do Empiric Models Outperform Physician Intuitive Estimates? A Multicenter Cohort Study.
    Alba AC; Buchan TA; Saha S; Fan S; Demers C; Poon S; Mak S; Al-Hesayen A; Toma M; Zieroth S; Anderson K; Porepa L; Chih S; Giannetti N; Rac V; Levy WC; Ross HJ; Guyatt GH
    Circ Heart Fail; 2023 Jul; 16(7):e010312. PubMed ID: 37337896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-type natriuretic peptide levels in obese patients with advanced heart failure.
    Horwich TB; Hamilton MA; Fonarow GC
    J Am Coll Cardiol; 2006 Jan; 47(1):85-90. PubMed ID: 16386669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the prognostic usefulness of N-terminal pro-brain natriuretic Peptide in patients with heart failure with versus without chronic kidney disease.
    Bruch C; Fischer C; Sindermann J; Stypmann J; Breithardt G; Gradaus R
    Am J Cardiol; 2008 Aug; 102(4):469-74. PubMed ID: 18678308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The utilization and prognostic impact of B-type Natriuretic Peptide in hospitalized acute decompensated heart failure in an Asian population.
    Chen LJ; Hung CL; Yeh HI; Jeng MJ; Su CH; Wu TY; Shih SC; Tsai CH
    BMC Cardiovasc Disord; 2016 Sep; 16(1):178. PubMed ID: 27613439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B-type natriuretic peptide assessment in ambulatory heart failure patients: insights from IMPROVE HF.
    Ambrosy AP; Fonarow GC; Albert NM; Curtis AB; Heywood JT; Mehra MR; O'Connor CM; Reynolds D; Walsh MN; Yancy CW; Gheorghiade M
    J Cardiovasc Med (Hagerstown); 2012 Jun; 13(6):360-7. PubMed ID: 22472850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.